![John Jordan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Jordan active positions
Companies | Position | Start | End |
---|---|---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Director/Board Member | - | - |
Director of Finance/CFO | - | - | |
Proteocyte Diagnostics, Inc.
![]() Proteocyte Diagnostics, Inc. Medical SpecialtiesHealth Technology Proteocyte Diagnostics, Inc. develops prognostic oral precancer laboratory, which objectively and accurately detects oral lesions. The company was founded in 2011 and is headquartered in Toronto, Canada. | Director/Board Member | - | - |
Director of Finance/CFO | - | - |
Career history of John Jordan
Statistics
International
Canada | 3 |
Operational
Director/Board Member | 2 |
Director of Finance/CFO | 2 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Health Technology |
Proteocyte Diagnostics, Inc.
![]() Proteocyte Diagnostics, Inc. Medical SpecialtiesHealth Technology Proteocyte Diagnostics, Inc. develops prognostic oral precancer laboratory, which objectively and accurately detects oral lesions. The company was founded in 2011 and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- John Jordan
- Experience